Renovascular hypertension: Balancing the controversies in diagnosis and treatment

Cleveland Clinic Journal of Medicine

Volumn 72, Issue 12, 2005, Pages 1135-1147

  Garovic, Vesna D ^a,b   Kane, Garvan C ^a   Schwartz, Gary L ^a  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; ATHEROSCLEROSIS; ATROPHY; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONSERVATIVE TREATMENT; COST BENEFIT ANALYSIS; COUGHING; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FIBROMUSCULAR DYSPLASIA; HUMAN; HYPERKALEMIA; KIDNEY ANGIOGRAPHY; KIDNEY FAILURE; KIDNEY FUNCTION; MUSCLE DISEASE; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN PRESERVATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RENOVASCULAR HYPERTENSION; REVASCULARIZATION; STENOSIS; STENT; TREATMENT INDICATION; REVIEW;

HUMANS; HYPERTENSION, RENOVASCULAR;

EID: 33644856926     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.72.12.1135     Document Type: Article

References (55)

1. Goldblatt HL, Hanzal RF, Summerville WW. Studies on experimental hypertension. I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 1934; 59:347-378.
2. Brunner HR, Kirshman JD, Sealey JE, Laragh JH. Hypertension of renal origin: evidence for two different mechanisms. Science 1971; 174:1344-1346.
3. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med 2001; 344:431-442.
4. Harding MB, Smith LR, Himmelstein SI, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol 1992; 2:1608-1616.
5. Olin JW, Melia M, Young JR, Graor RA, Risius B. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med 1990; 88:46N-51N.
6. Cicuto KP, McLean GK, Oleaga JA, Freiman DB, Grossman RA, Ring EJ. Renal artery stenosis: anatomic classification for percutaneous transluminal angioplasty. AJR Am J Roentgenol 1981; 137:599-601.
7. Bonelli FS, McKusick MA, Textor SC, et al. Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo Clin Proc 1995; 70:1041-1052.
8. Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis 1994; 24:622-629.
9. Greco BA, Breyer JA. The natural history of renal artery stenosis: who should be evaluated for suspected ischemic nephropathy? Semin Nephrol 1996; 16:2-11.
10. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 1984; 11:383-392.
11. Tollefson DF, Ernst CB. Natural history of atherosclerotic renal artery stenosis associated with aortic disease. J Vasc Surg 1991; 14:327-331.
12. Caps MT, Perissinotto C, Zierler RE, et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998; 98:2866-2872.
13. Textor SC. Ischemic nephropathy: where are we now? J Am Soc Nephrol 2004; 15:1974-1982.
14. Lerman L, Textor SC. Pathophysiology of ischemic nephropathy. Urol Clin North Am 2001; 28:793-803.
15. Textor SC, Wilcox CS. Renal artery stenosis: a common, treatable cause of renal failure? Annu Rev Med 2001; 52:421-442.
16. Zucchelli PC. Hypertension and atherosclerotic renal artery stenosis: diagnostic approach. J Am Soc Nephrol 2002; 13(suppl 3):S184-S186.
17. Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, de Leeuw PW, van Engelshoven JM. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med 2001; 135:401-411.
18. Vasbinder GB, Nelemans PJ, Kessels AG, et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med 2004; 141:674-682.
19. Huot SJ, Hansson JH, Dey H, Concato J. Utility of captopril renal scans for detecting renal artery stenosis. Arch Intern Med 2002; 162:1981-1984.
20. Krijnen P, van Jaarsveld BC, Steyerberg EW, Man in 't Veld AJ, Schalekamp MA, Habbema JD. A clinical prediction rule for renal artery stenosis. Ann Intern Med 1998; 129:705-711.
21. Franklin SS, Smith RD. Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension. Am J Med 1985; 79(3C):14-23.
22. Hollenberg NK. Medical therapy for renovascular hypertension: a review. Am J Hypertens 1988; 1:338S-343S.
23. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators [erratum appears in N Engl J Med 2000, 342:1376]. N Engl J Med 2000; 342:145-153.
24. Hricik DE, Browning PJ, Kopelman R, Goorno WE, Madias NE, Dzau VJ. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N Engl J Med 1983; 308:373-376.
25. Textor SC. Renal failure related to angiotensin-converting enzyme inhibitors. Semin Nephrol 1997;17:67-76.
26. Jackson B, Matthews PG, McGrath BP, Johnston CI. Angiotensin converting enzyme inhibition in renovascular hypertension: frequency of reversible renal failure. Lancet 1984; 1:225-226.
27. Ahmed A. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine? J Am Geriatr Soc 2002; 50:1297-1300.
28. Palmer BF. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what to do if the serum creatinine and/or serum potassium concentration rises. Nephrol Dial Transplant 2003; 18:1973-1975.
29. van de Ven PJ, Beutler JJ, Kaatee R, Beek FJ, Mali WP, Koomans HA. Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease. Kidney Int 1998; 53:986-993.
30. Devoy MA. Tomson CR, Edmunds ME, Feehally J, Walls J. Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversible. J Intern Med 1992; 232:493-498.
31. Veniant M, Heudes D, Clozel JP, Bruneval P, Menard J. Calcium blockade versus ACE inhibition in clipped and unclipped kidneys of 2K-1C rats. Kidney Int 1994, 46:421-429.
32. Bakris GL, Siomos M, Richardson D, et al. ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. Kidney Int 2000; 58:2084-2092.
33. Khong TK, Missouris CG, Belli AM, MacGregor GA. Regression of atherosclerotic renal artery stenosis with aggressive lipid lowering therapy. J Hum Hypertens 2001; 15:431-433.
34. Sos TA, Pickering TG, Sniderman K, et al. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 1983; 309:274-279.
35. Bell GM, Reid J, Buist TA. Percutaneous transluminal angioplasty improves blood pressure and renal function in renovascular hypertension. Q J Med 1987; 63:393-403.
36. Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies. Q J Med 1999; 92:159-167.
37. Dorros G, Jaff M, Mathiak L, et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998; 98:642-647.
38. van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999; 353:282-286.
39. Lamawansa MD, Bell R, Kumar A, House AK. Radiological predictors of response to renovascular reconstructive surgery. Ann R Coll Surgeons Engl 1995; 77:337-341.
40. Hansen KJ, Starr SM, Sands RE, Burkart JM, Plonk GW Jr, Dean RH. Contemporary surgical management of renovascular disease. J Vasc Surg 1992; 16:319-330.
41. Cambria RP, Brewster DC, L'Italien GJ, et al. Renal artery reconstruction for the preservation of renal function. J Vasc Surg 1996; 24:371-380.
42. Radermacher J, Chavan A, Bleck J, et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001; 344:410-417.
43. Dorros G, Jaff M, Jain A, Dufek C, Mathiak L. Follow-up of primary Palmaz-Schatz stent placement for atherosclerotic renal artery stenosis. Am J Cardiol 1995; 75:1051-1055.
44. Harden PN, MacLeod MJ, Rodger RS, et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 1997; 349:1133-1136.
45. Gami AS, Garovic VD. Contrast nephropathy after coronary angiography [erratum appears in Mayo Clin Proc 2004; 79:432]. Mayo Clin Proc 2004; 79:211-219.
46. Pohl MA, Novick AC. Natural history of atherosclerotic and fibrous renal artery disease: clinical implications. Am J Kidney Dis 1985; 5:A120-A130.
47. Plouin PF, Chatellier G, Dame B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998; 31:823-829.
48. van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000; 342:1007-1014.
49. Webster J, Marshall F, Abdalla M, et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998; 12:329-335.
50. Nordmann AJ, Woo K, Parkes R, Logan AG. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med 2003; 114:44-50.
51. Ives NJ, Wheatley K, Stowe RL, et al. Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. Nephrol Dial Transplant 2003; 18:298-304.
52. Oliveira GH, Garovic VD. 23-year-old man with hypertension and flank trauma. Mayo Clin Proc 2002; 77:1229-1232.
53. Bunchman TE, Sinaiko AR. Renovascular hypertension presenting with hypokalemic metabolic alkalosis. Pediatr Nephrol 1990; 4:169-170.
54. Rudnick MR, Maxwell MM. Limitations of renin assays. In: Narins RG, editor. Controversies in Nephrology and Hypertension. New York: Churchill Livingstone; 1984:123-160.
55. Kane GC, Textor SC, Schirger A, Garovic VD. Revisiting the role of nephrectomy for advanced renovascular disease. Am J Med 2003; 114:729-735.